THV Field Leader – St. Louis Territory

Edwards Lifesciences Belgium; St. Louis (MO); On-site; USD 90,000 - 150,000; Full time

Benefits offered by this job

Competitive salary

Performance-based incentives

Benefits programs

Job summary

Edwards Lifesciences USA is seeking a field-based THV Sales professional to develop the THV market in a dedicated territory. You will partner with Field Clinical Specialists and the Regional Director to educate clinicians and support positive patient outcomes.

This role requires deep interventional cardiology knowledge, strong sales experience, and the ability to train staff while driving growth and building trust with cardiologists and surgeons. Travel up to 50% is expected.

Qualifications

• Bachelor’s degree and five years of progressive sales experience or equivalent per Edwards criteria.
• Medical Device industry experience or equivalent per Edwards criteria.
• Expertise in catheter-delivered technology and hands-on clinician training is preferred.

Responsibilities

• Develop THV market in the assigned territory.
• Partner with Field Clinical Specialists and Regional Director to educate clinicians.
• Drive THV product penetration and establish new business with customers.
• Coordinate site training and proctoring with Education team and Sales strategy.
• Present patient selection to Cardiologists and Surgeons; achieve sales targets.
• Forecast by account, product and therapy; manage territory expenses.

Skills

Interventional cardiology knowledge

Sales experience

Training abilities

Customer relationship building

Travel willingness

Education

Bachelor's degree in related field

Job description

Edwards Lifesciences USA is seeking a field-based THV Sales professional to develop the THV market in a dedicated territory. You will partner with Field Clinical Specialists and the Regional Director to educate clinicians and support positive patient outcomes.

This role requires deep interventional cardiology knowledge, strong sales experience, and the ability to train staff while driving growth and building trust with cardiologists and surgeons. Travel up to 50% is expected.